Exciting Progress in SCN8A Research: Positive Initial Results from the Praxis EMBOLD Study We are pleased to share an update from Praxis Precision Medicines regarding the EMBOLD study, which has shown some initial promising results in SCN8A and SCN2A developmental and epileptic encephalopathy (DEE) patients. These findings are exciting as we know there is substantial […]